The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Dec 2019 16:30

RNS Number : 2610W
Omega Diagnostics Group PLC
09 December 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

OMEGA DIAGNOSTICS GROUP PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

ORYX INTERNATIONAL GROWTH FUND LIMITED

City and country of registered office (if applicable)

GUERNSEY

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

06/12/2019

6. Date on which issuer notified (DD/MM/YYYY):

09/12/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.98%

10.98%

150,307,010

Position of previous notification (if

applicable)

11.14%

11.14%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B1VCP282

16,500,000

10.98%

SUBTOTAL 8. A

16,500,000

10.98%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

GUERNSEY

Date of completion

09/12/2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUKUNRKWAURAA
Date   Source Headline
7th Aug 20204:41 pmRNSSecond Price Monitoring Extn
7th Aug 20204:35 pmRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSUpdate on progress of UK-Rapid Test Consortium
24th Jul 20209:45 amRNSExercise of Options and Total Voting Rights
23rd Jul 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jul 20202:00 pmRNSPrice Monitoring Extension
23rd Jul 202012:45 pmRNSNotice of AGM and posting of Annual Report
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 20202:00 pmRNSPrice Monitoring Extension
20th Jul 202011:45 amRNSInvestor presentation
20th Jul 202011:05 amRNSSecond Price Monitoring Extn
20th Jul 202011:00 amRNSPrice Monitoring Extension
16th Jul 20209:05 amRNSSecond Price Monitoring Extn
16th Jul 20209:00 amRNSPrice Monitoring Extension
15th Jul 20204:13 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSFinal Results
13th Jul 202011:39 amRNSHolding(s) in Company
10th Jul 202011:23 amRNSResult of General Meeting
10th Jul 20207:00 amRNSNotice of Results
8th Jul 20207:00 amRNSResult of Open Offer – full take up
2nd Jul 20207:08 amRNSApproval for sale in India
29th Jun 20202:06 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 202010:08 amRNSHolding(s) in Company
29th Jun 20207:00 amRNSUpdate on progress of UK-Rapid Test Consortium
22nd Jun 20202:15 pmRNSPublication of Shareholder Circular
22nd Jun 20207:00 amRNSInvestor presentation
19th Jun 20209:32 amRNSFundraising to raise gross proceeds of up to £11m
9th Jun 20209:05 amRNSSecond Price Monitoring Extn
9th Jun 20209:00 amRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSTrading Update
3rd Jun 20209:04 amRNSUpdate on progress of UK-Rapid Test Consortium
1st Jun 202012:31 pmRNSHolding(s) in Company
28th May 20202:47 pmRNSExercise of Options and TVR
28th May 20202:06 pmRNSSecond Price Monitoring Extn
28th May 20202:01 pmRNSPrice Monitoring Extension
27th May 20204:41 pmRNSSecond Price Monitoring Extn
27th May 20204:35 pmRNSPrice Monitoring Extension
27th May 20203:53 pmRNSStmnt re Share Price Movement
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
27th May 202011:05 amRNSSecond Price Monitoring Extn
27th May 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.